Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 10236
Country/Region: Zambia
Year: 2017
Main Partner: University Teaching Hospital - Zambia
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $12,572,320 Additional Pipeline Funding: $3,500,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,000,000
Care: Orphans and Vulnerable Children (HKID) $378,397
Care: TB/HIV (HVTB) $850,000
Care: Pediatric Care and Support (PDCS) $600,000
Laboratory Infrastructure (HLAB) $73,288
Strategic Information (HVSI) $8,189
Testing: HIV Testing and Counseling (HVCT) $475,427
Sexual Prevention: Other Sexual Prevention (HVOP) $95,693
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $491,326
Treatment: Adult Treatment (HTXS) $7,600,000
Treatment: Pediatric Treatment (PDTX) $1,000,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 129,823
HTS_TST Service Delivery Point (Community) Homebased testing: 1-9, Negative 2018 112
HTS_TST Service Delivery Point (Community) Homebased testing: 10-14, Female, Negative 2018 65
HTS_TST Service Delivery Point (Community) Homebased testing: 10-14, Male, Negative 2018 65
HTS_TST Service Delivery Point (Community) Homebased testing: 15-19, Female, Negative 2018 636
HTS_TST Service Delivery Point (Community) Homebased testing: 15-19, Male, Negative 2018 692
HTS_TST Service Delivery Point (Community) Homebased testing: 20-24, Female, Negative 2018 387
HTS_TST Service Delivery Point (Community) Homebased testing: 20-24, Male, Negative 2018 387
HTS_TST Service Delivery Point (Community) Homebased testing: 25-49, Female, Negative 2018 332
HTS_TST Service Delivery Point (Community) Homebased testing: 25-49, Male, Negative 2018 277
HTS_TST Service Delivery Point (Community) Homebased testing: 50+, Female, Negative 2018 28
HTS_TST Service Delivery Point (Community) Homebased testing: 50+, Male, Negative 2018 28
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 298
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2018 324
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 181
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2018 181
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Female, Negative 2018 155
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 129
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2018 13
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2018 13
HTS_TST Service Delivery Point (Community) Mobile Testing: 1-9, Negative 2018 112
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2018 65
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2018 65
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2018 694
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2018 754
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2018 422
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2018 422
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Female, Negative 2018 362
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative 2018 302
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2018 30
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2018 30
HTS_TST Service Delivery Point (Community) VCT Mod: 1-9, Negative 2018 17
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Female, Negative 2018 10
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Male, Negative 2018 10
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2018 293
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2018 319
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2018 178
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2018 178
HTS_TST Service Delivery Point (Community) VCT Mod: 25-49, Female, Negative 2018 153
HTS_TST Service Delivery Point (Community) VCT Mod: 25-49, Male, Negative 2018 127
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2018 13
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2018 13
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 14
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 1,809
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 5,131
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 10,084
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 37
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 398
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 1,682
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 913
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 911
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 454
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 278
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 700
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 437
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 1,174
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 992
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 170
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 139
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 548
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 2,718
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 1,392
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 1,393
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 335
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 587
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 600
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 614
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 1,058
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 1,045
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 141
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 124
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 128
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 181
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 93
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 93
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 2,224
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 3,900
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 4,084
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 4,079
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 7,023
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 6,941
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 936
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 832
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 1,545
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 3
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 4
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 5
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 8
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2018 147
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 1,579
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 542
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 542
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 3,660
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 2,446
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 5,350
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 3,654
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 9,246
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 7,956
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 1,212
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 1,030
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 36
HTS_TST Sum of Test Result disaggregates 2018 15,594
HTS_TST_POS By Test Result: Positive 2018 15,594
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 1-9, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 15-19, Female, Positive 2018 87
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 15-19, Male, Positive 2018 94
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 20-24, Female, Positive 2018 53
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 20-24, Male, Positive 2018 53
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 25-49, Female, Positive 2018 45
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 25-49, Male, Positive 2018 38
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 50+, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Community) Homebased testing: 50+, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2018 26
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2018 28
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 16
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2018 16
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 11
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 1-9, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 1-9, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 359
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 1,024
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 2,023
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 33
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 37
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 23
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 62
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 38
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 101
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 86
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 29
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 144
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 72
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 72
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 174
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 305
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 312
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 319
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 550
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 543
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 73
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 64
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 277
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 481
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 494
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 504
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 868
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 758
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 116
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 103
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 81
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 82
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 28
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 28
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 499
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 334
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 729
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 501
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 1,260
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 1,085
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 164
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 142
OVC_SERV Age/Sex: 1-9 2018 221
OVC_SERV Age/Sex: 10-14 Female 2018 550
OVC_SERV Age/Sex: 10-14 Male 2018 550
OVC_SERV Age/Sex: 15-17 Female 2018 550
OVC_SERV Age/Sex: 15-17 Male 2018 550
OVC_SERV By: Age/sex: 18-24 Female 2018 550
OVC_SERV By: Age/sex: Male 18-24 2018 550
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 3,521
OVC_SERV Program Completion: Active 2018 3,521
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 18-24 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 10-14 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 15-17 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 18-24 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 10-14 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 15-17 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 18-24 2018 275
OVC_SERV Sum of Age/Sex disaggregates 2018 2,200
PMTCT_ART Already on ART at beginning of current pregnancy 2018 1,710
PMTCT_ART New on ART 2018 1,536
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 3,246
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 22,420
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 3,251
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,511
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 1,620
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 58
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 62
PMTCT_STAT By Age (Numerator): 10-14 2018 17
PMTCT_STAT By Age (Numerator): 15-19 2018 2,372
PMTCT_STAT By Age (Numerator): 20-24 2018 6,730
PMTCT_STAT By Age (Numerator): 25-49 2018 13,250
PMTCT_STAT By Age (Numerator): 50+ 2018 51
PMTCT_STAT By Number of known positives: 15-19 2018 201
PMTCT_STAT By Number of known positives: 20-24 2018 576
PMTCT_STAT By Number of known positives: 25-49 2018 1,151
PMTCT_STAT By Number of known positives: 50+ 2018 1
PMTCT_STAT By Number of new negative: 10-14 2018 16
PMTCT_STAT By Number of new negative: 15-19 2018 2,012
PMTCT_STAT By Number of new negative: 20-24 2018 5,708
PMTCT_STAT By Number of new negative: 25-49 2018 11,220
PMTCT_STAT By Number of new negative: 50+ 2018 48
PMTCT_STAT By Number of new positives: 10-14 2018 1
PMTCT_STAT By Number of new positives: 15-19 2018 159
PMTCT_STAT By Number of new positives: 20-24 2018 446
PMTCT_STAT By Number of new positives: 25-49 2018 879
PMTCT_STAT By Number of new positives: 50+ 2018 2
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 22,420
PMTCT_STAT_den By Age (Denominator): <15-19 2018 2,498
PMTCT_STAT_den By Age (Denominator): 10-14 2018 19
PMTCT_STAT_den By Age (Denominator): 20-24 2018 7,084
PMTCT_STAT_den By Age (Denominator): 25-49 2018 13,945
PMTCT_STAT_den By Age (Denominator): 50+ 2018 52
PP_PREV Age/sex: 10-14 Female 2018 2,837
PP_PREV Age/sex: 10-14 Male 2018 2,837
PP_PREV Age/sex: 15-19 Female 2018 5,675
PP_PREV Age/sex: 15-19 Male 2018 5,675
PP_PREV Age/sex: 20-24 Female 2018 5,675
PP_PREV Age/sex: 20-24 Male 2018 5,673
PP_PREV Age/sex: 25-49 Female 2018 3,786
PP_PREV Age/sex: 25-49 Male 2018 3,788
PP_PREV Age/sex: 50+ Female 2018 945
PP_PREV Age/sex: 50+ Male 2018 945
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 37,836
PP_PREV Sum of Age/Sex disaggregates 2018 37,836
PrEP_NEW Female 20-24 2018 100
PrEP_NEW FSW 2018 500
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2018 500
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 106
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 4
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 153
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 267
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 264
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 109
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 4
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 153
TB_PREV By Age/Sex (Numerator): <15, Male 2018 4
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 103
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 141
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 248
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 3,403
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 50
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 1,416
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 1,937
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 7
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 260
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 9
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 402
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 678
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 703
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 7
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 269
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 9
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 418
TX_CURR Age/Sex: <1 2018 43
TX_CURR Age/Sex: <1-9 2018 772
TX_CURR Age/Sex: 10-14 Female 2018 969
TX_CURR Age/Sex: 10-14 Male 2018 1,092
TX_CURR Age/Sex: 15-19 Female 2018 979
TX_CURR Age/Sex: 15-19 Male 2018 714
TX_CURR Age/Sex: 20-24 Female 2018 2,362
TX_CURR Age/Sex: 20-24 Male 2018 1,311
TX_CURR Age/Sex: 25-49 Female 2018 12,198
TX_CURR Age/Sex: 25-49 Male 2018 7,318
TX_CURR Age/Sex: 50+ Female 2018 948
TX_CURR Age/Sex: 50+ Male 2018 826
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 23,711
TX_CURR Sum of age/sex disaggregates 2018 1,693
TX_NEW Breastfeeding status 2018 576
TX_NEW By Age/Sex: <1 2018 40
TX_NEW By Age/Sex: 1-9 2018 263
TX_NEW By Age/Sex: 10-14 Female 2018 130
TX_NEW By Age/Sex: 10-14 Male 2018 165
TX_NEW By Age/Sex: 15-19 Female 2018 1,209
TX_NEW By Age/Sex: 15-19 Male 2018 1,044
TX_NEW By Age/Sex: 20-24 Female 2018 2,270
TX_NEW By Age/Sex: 20-24 Male 2018 1,205
TX_NEW By Age/Sex: 25-49 Female 2018 4,152
TX_NEW By Age/Sex: 25-49 Male 2018 2,177
TX_NEW By Age/Sex: 50+ Female 2018 341
TX_NEW By Age/Sex: 50+ Male 2018 279
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 13,274
TX_NEW Pregnancy status 2018 579
TX_NEW Sum of Age/Sex disaggregates 2018 12,972
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 26,868
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 24,180
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,241
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,351
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 13,352
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 8,236
TX_PVLS Numerator: Indication: Routine 2018 24,180
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,382
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,505
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 14,833
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 9,150
TX_PVLS_den Denominator: Indication: Routine 2018 26,868
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 228
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 258
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,215
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 3,665
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 10,366
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 13,275
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 286
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 320
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7,970
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 4,699
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 20,891
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 260
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 2
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 3
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 111
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 144
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 150
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 262
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 8,900
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 11,579
Cross Cutting Budget Categories and Known Amounts Total: $600,000
Gender: Gender Equality $100,000
Equity in HIV prevention, care, treatment and support
Food and Nutrition: Policy, Tools, and Service Delivery $100,000
Motor Vehicles: Purchased $200,000
Human Resources for Health $200,000